FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2219264704> ?p ?o ?g. }

• W2219264704 abstract "Lung cancer is the leading cause of cancer deaths worldwide. Surgery, radiotherapy at conventional and high dose and chemotherapy are the mainstay for lung cancer treatment. Insufficient migration and activation of tumour specific effector T cells seem to be important reasons for inadequate host anti-tumour immune response. Ionizing radiation can induce a variety of immune responses. The goal of this randomized trial is to assess if a preoperative single fraction low dose radiation is able to improve anti-tumour immune response in operable early stage lung cancer. This trial has been designed as an investigator-initiated, prospective, randomized, 2-armed phase II trial. Patients who are candidates for elective resection of early stage non-small cell lung cancer will be randomized into 2 arms. A total of 36 patients will be enrolled. The patients receive either 2 Gy or no radiation prescribed to their primary tumour. Radiation will be delivered by external beam radiotherapy using 3D radiotherapy or intensity-modulated radiation technique (IMRT) 7 days prior to surgical resection. The primary objective is to compare CD8+ T cell counts detected by immunohistochemistry in resected tumours following preoperative radiotherapy versus no radiotherapy. Secondary objectives include the association between CD8+ T cell counts and progression free survival, the correlation of CD8+ T cell counts quantified by immunohistochemistry and flow cytometry, local tumour control and recurrence patterns, survival, radiogenic treatment toxicity and postoperative morbidity and mortality. Further, frequencies of tumour reactive T cells in blood and bone marrow as well as whole blood cell transcriptomics and plasma-proteomics will be correlated with clinical outcome. This unique intervention combining preoperative low dose radiation and surgical removal of early stage non-small cell lung cancer is designed to address the problem of inadequate host anti-tumour immune response. If successful, this study may affect the role of radiotherapy in lung cancer treatment. NCT02319408 ; Registration: December 29, 2014." @default.
• W2219264704 created "2016-06-24" @default.
• W2219264704 creator A5029575769 @default.
• W2219264704 creator A5044726711 @default.
• W2219264704 creator A5046577049 @default.
• W2219264704 creator A5052004888 @default.
• W2219264704 creator A5054523771 @default.
• W2219264704 creator A5065509965 @default.
• W2219264704 creator A5074217213 @default.
• W2219264704 creator A5078003238 @default.
• W2219264704 creator A5080547151 @default.
• W2219264704 creator A5086658735 @default.
• W2219264704 date "2015-12-01" @default.
• W2219264704 modified "2023-09-27" @default.
• W2219264704 title "A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)" @default.
• W2219264704 cites W1584501990 @default.
• W2219264704 cites W1708153904 @default.
• W2219264704 cites W1710915557 @default.
• W2219264704 cites W1740332796 @default.
• W2219264704 cites W1895620535 @default.
• W2219264704 cites W1974084284 @default.
• W2219264704 cites W1974608253 @default.
• W2219264704 cites W1978455851 @default.
• W2219264704 cites W1980474981 @default.
• W2219264704 cites W1981989535 @default.
• W2219264704 cites W2009501181 @default.
• W2219264704 cites W2013607058 @default.
• W2219264704 cites W2017103032 @default.
• W2219264704 cites W2018653467 @default.
• W2219264704 cites W2022652983 @default.
• W2219264704 cites W2024384252 @default.
• W2219264704 cites W2027824109 @default.
• W2219264704 cites W2034949179 @default.
• W2219264704 cites W2038600538 @default.
• W2219264704 cites W2049491375 @default.
• W2219264704 cites W2054841768 @default.
• W2219264704 cites W2066699971 @default.
• W2219264704 cites W2068016962 @default.
• W2219264704 cites W2070491766 @default.
• W2219264704 cites W2071793654 @default.
• W2219264704 cites W2073193910 @default.
• W2219264704 cites W2079936875 @default.
• W2219264704 cites W2080571923 @default.
• W2219264704 cites W2091098205 @default.
• W2219264704 cites W2092998234 @default.
• W2219264704 cites W2100406304 @default.
• W2219264704 cites W2104504726 @default.
• W2219264704 cites W2105039222 @default.
• W2219264704 cites W2110252240 @default.
• W2219264704 cites W2110996227 @default.
• W2219264704 cites W2117843535 @default.
• W2219264704 cites W2124606550 @default.
• W2219264704 cites W2132564070 @default.
• W2219264704 cites W2132874160 @default.
• W2219264704 cites W2141423844 @default.
• W2219264704 cites W2142300779 @default.
• W2219264704 cites W2153932922 @default.
• W2219264704 cites W2160613616 @default.
• W2219264704 cites W2161817637 @default.
• W2219264704 cites W2165945881 @default.
• W2219264704 cites W2584148894 @default.
• W2219264704 cites W4229882638 @default.
• W2219264704 cites W4234236664 @default.
• W2219264704 cites W4239337844 @default.
• W2219264704 cites W4242768823 @default.
• W2219264704 cites W44099323 @default.
• W2219264704 doi "https://doi.org/10.1186/s12885-015-2006-2" @default.
• W2219264704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4684916" @default.
• W2219264704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26686362" @default.
• W2219264704 hasPublicationYear "2015" @default.
• W2219264704 type Work @default.
• W2219264704 sameAs 2219264704 @default.
• W2219264704 citedByCount "12" @default.
• W2219264704 countsByYear W22192647042017 @default.
• W2219264704 countsByYear W22192647042018 @default.
• W2219264704 countsByYear W22192647042019 @default.
• W2219264704 countsByYear W22192647042021 @default.
• W2219264704 countsByYear W22192647042023 @default.
• W2219264704 crossrefType "journal-article" @default.
• W2219264704 hasAuthorship W2219264704A5029575769 @default.
• W2219264704 hasAuthorship W2219264704A5044726711 @default.
• W2219264704 hasAuthorship W2219264704A5046577049 @default.
• W2219264704 hasAuthorship W2219264704A5052004888 @default.
• W2219264704 hasAuthorship W2219264704A5054523771 @default.
• W2219264704 hasAuthorship W2219264704A5065509965 @default.
• W2219264704 hasAuthorship W2219264704A5074217213 @default.
• W2219264704 hasAuthorship W2219264704A5078003238 @default.
• W2219264704 hasAuthorship W2219264704A5080547151 @default.
• W2219264704 hasAuthorship W2219264704A5086658735 @default.
• W2219264704 hasBestOaLocation W22192647041 @default.
• W2219264704 hasConcept C121608353 @default.
• W2219264704 hasConcept C126322002 @default.
• W2219264704 hasConcept C142724271 @default.
• W2219264704 hasConcept C143998085 @default.
• W2219264704 hasConcept C168563851 @default.
• W2219264704 hasConcept C203014093 @default.
• W2219264704 hasConcept C2776256026 @default.
• W2219264704 hasConcept C2780140570 @default.
• W2219264704 hasConcept C509974204 @default.
• W2219264704 hasConcept C71924100 @default.

• next